Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Pigment cell transplantation appears helpful for treating patients with stable vitiligo

19.10.2004


Patients with stable vitiligo, a skin disorder characterized by patches of lighter colored, or depigmented skin, may achieve good repigmentation of these areas with skin transplants using skin taken from normally-pigmented areas of their own bodies, according to two articles in the October issue of The Archives of Dermatology, one of the JAMA/Archives journals.



According to the articles, vitiligo is one of the most common pigment cell disorders, distinguished by depigmented patches of skin. Approximately one percent of the world population has vitiligo, whose psychosocial impact is often underestimated, the article states. The standard treatment for vitiligo is ultraviolet (UV) light therapy, which may last several months and can cause physical discomfort. Transplantation of pigment cells (called melanocytes) is another treatment option in patients with vitiligo.

Nanny van Geel, M.D., of Ghent University Hospital, Belgium, and colleagues investigated the efficacy of using transplanted pigment cells to treat 28 patients with vitiligo.


Patients were divided into two groups: patients with stable vitiligo (no new depigmented patches in the past 12 months, n=19) and patients whose vitiligo was not stable (n=9). The researchers selected 33 pairs of depigmented skin patches on the patients- one patch was randomly assigned to be treated with grafted pigment cells, the other was given a sham transplant. Pigment cells were taken from each patient from a site where the skin was normally pigmented. Three weeks after surgery, all patches received UV irradiation therapy twice per week for approximately two months.

The researchers found that there was a significant difference between pigment cell graft sites and placebo graft sites after three, six and 12 months. In patients with stable vitiligo, repigmentation of at least 70 percent of the treated area was achieved in 55 percent, 57 percent, and 77 percent of the actively treated lesions at three, six and twelve months after treatment. In group two, repigmentation of at least 70 percent of the treated area was not achieved at any time point. Repigmentation was diffuse on 94 percent of responding patients. "After a strict preoperative selection for disease stability, transplantation resulted in repigmentation of at least 70 percent of the treated area in most actively treated vitiligo lesions," the authors write.

In another study, Sanjeev V. Mulekar, M.D., of the Noble Clinic, Pune, India investigated the long-term efficacy of skin cell transplantation in 67 patients with vitiligo. Dr. Mulekar used a melanocyte-keratinocyte cell mixture (pigment cells and structural skin cells) taken from normally-pigmented sites on the patients’ own bodies. Patients were followed up for five years.

Dr. Mulekar found that 41 patients (84 percent) with segmental vitiligo (located in a few similar locations on each side of the body, such as around the mouth or on the hands) had 95 percent to 100 percent repigmentation in the treated areas. In patients with focal vitiligo, 73 percent had 95 percent to 100 percent repigmentation in treated areas. These results remained throughout the follow-up period. "Melanocyte-keratinocyte cell transplantation is a simple, safe, and effective surgical therapy," Dr. Mulekar writes. "Patients with segmental and focal vitiligo can experience a prolonged disease-free period, which may extend through the rest of their lives."

Jean Marie Naeyaert | EurekAlert!
Further information:
http://jama.ama-assn.org
http://www.vsnl.com
http://www.medsci.uu.se

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>